These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17047488)

  • 21. Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
    Aquilante CL; Kiser JJ; Anderson PL; Christians U; Kosmiski LA; Daily EB; Hoffman KL; Hopley CW; Predhomme JA; Schniedewind B; Sidhom MS
    J Clin Pharmacol; 2012 Nov; 52(11):1725-38. PubMed ID: 22174437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
    Pasanen MK; Neuvonen M; Neuvonen PJ; Niemi M
    Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population.
    Sai K; Saito Y; Itoda M; Fukushima-Uesaka H; Nishimaki-Mogami T; Ozawa S; Maekawa K; Kurose K; Kaniwa N; Kawamoto M; Kamatani N; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Matsumura Y; Ohtsu A; Saijo N; Sawada J
    Drug Metab Pharmacokinet; 2008; 23(2):139-47. PubMed ID: 18445995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.
    Niemi M; Neuvonen PJ; Hofmann U; Backman JT; Schwab M; Lütjohann D; von Bergmann K; Eichelbaum M; Kivistö KT
    Pharmacogenet Genomics; 2005 May; 15(5):303-9. PubMed ID: 15864131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
    Lubomirov R; di Iulio J; Fayet A; Colombo S; Martinez R; Marzolini C; Furrer H; Vernazza P; Calmy A; Cavassini M; Ledergerber B; Rentsch K; Descombes P; Buclin T; Decosterd LA; Csajka C; Telenti A;
    Pharmacogenet Genomics; 2010 Apr; 20(4):217-30. PubMed ID: 20139798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans.
    Oh ES; Kim CO; Cho SK; Park MS; Chung JY
    Drug Metab Pharmacokinet; 2013; 28(3):196-202. PubMed ID: 23007012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRP2 haplotypes confer differential susceptibility to toxic liver injury.
    Choi JH; Ahn BM; Yi J; Lee JH; Lee JH; Nam SW; Chon CY; Han KH; Ahn SH; Jang IJ; Cho JY; Suh Y; Cho MO; Lee JE; Kim KH; Lee MG
    Pharmacogenet Genomics; 2007 Jun; 17(6):403-15. PubMed ID: 17502832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
    Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
    Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y; Miura M; Sunagawa S; Kagaya H; Yasui-Furukori N; Uno T
    Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects.
    Cao K; Ren G; Lu C; Wang Y; Tan Y; Zhou J; Zhang Y; Lu Y; Li N; Chen X; Zhao D
    Eur J Clin Pharmacol; 2020 Jan; 76(1):51-59. PubMed ID: 31677118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
    Nguyen TD; Markova S; Liu W; Gow JM; Baldwin RM; Habashian M; Relling MV; Ratain MJ; Kroetz DL
    Pharmacogenomics J; 2013 Oct; 13(5):396-402. PubMed ID: 22664480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate.
    Pasanen MK; Miettinen TA; Gylling H; Neuvonen PJ; Niemi M
    Pharmacogenet Genomics; 2008 Oct; 18(10):921-6. PubMed ID: 18794729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid.
    Tornio A; Vakkilainen J; Neuvonen M; Backman JT; Neuvonen PJ; Niemi M
    Pharmacogenet Genomics; 2015 Aug; 25(8):382-7. PubMed ID: 26020121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing.
    Rohrbacher M; Kirchhof A; Skarke C; Geisslinger G; Lötsch J
    Pharmacogenomics; 2006 Mar; 7(2):167-76. PubMed ID: 16515396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
    Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
    J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics.
    Mwinyi J; Johne A; Bauer S; Roots I; Gerloff T
    Clin Pharmacol Ther; 2004 May; 75(5):415-21. PubMed ID: 15116054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
    Kalliokoski A; Backman JT; Neuvonen PJ; Niemi M
    Pharmacogenet Genomics; 2008 Nov; 18(11):937-42. PubMed ID: 18854776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.
    Tsujimoto M; Hatozaki D; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Ther Apher Dial; 2012 Dec; 16(6):580-7. PubMed ID: 23190519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
    Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
    Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin.
    Keskitalo JE; Pasanen MK; Neuvonen PJ; Niemi M
    Pharmacogenomics; 2009 Oct; 10(10):1617-24. PubMed ID: 19842935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.